Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs [PDF]
Drugs in Context, 2018 Background: Persons who inject drugs (PWID) are at increased risk of acute bacterial skin and skin structure infections (ABSSSIs), a growing healthcare concern.
Pedro Luis Gonzalez +5 more
doaj +3 more sources
Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis [PDF]
Antibiotics, 2019 This meta-analysis aims to assess the efficacy and safety of tedizolid, compared to linezolid, in the treatment of acute bacterial skin and skin structure infection (ABSSSI). PubMed, Web of Science, EBSCO (Elton B.
Shao-Huan Lan +6 more
doaj +3 more sources
Anti-MRSA Cephalosporin versus Vancomycin-Based Treatment for Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [PDF]
Antibiotics, 2021 This systematic review and meta-analysis of randomized controlled trials (RCTs) compared the clinical efficacy and safety of anti-MRSA cephalosporin and vancomycin-based treatment in treating acute bacterial skin and skin structure infections (ABSSSIs ...
Ching-Yi Chen +4 more
doaj +2 more sources
Severe Acute Bacterial Skin and Skin Structure Infection Following Fish Spine Injury: A Case Report and Literature Review [PDF]
Infection and Drug ResistanceLing Yang,1 Zhiwen Zhang,2 Qing Liang,2 Hao Zhang,1 Yijin Wang,1 Chao Zhuo1 1Department of Infection Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, People’s Republic of China; 2Emergency Department,
Yang L +5 more
doaj +2 more sources
Journal of Global Antimicrobial Resistance, 2021 : Objectives: This study aimed to evaluate the efficacy and safety of oritavancin (ORI) versus comparators for the treatment of acute bacterial skin and skin-structure infections (ABSSSIs) based on available clinical studies.
Huan Zhang +3 more
doaj +3 more sources
Journal of Global Antimicrobial Resistance, 2020 Objectives: The aim of this survey was to identify a set of actions aimed to improve the diagnosis and management of acute bacterial skin and skin-structure infections (ABSSSIs) and the implementation of some principles of antimicrobial stewardship (AMS)
Alex Soriano +3 more
doaj +3 more sources
Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease departments in Greece, Italy and Spain: a scenario analysis [PDF]
BMJ Open, 2019 Objective The aim of the analysis is to assess the organisational and economic consequences of adopting an early discharge strategy for the treatment of acute bacterial skin and skin structure infection (ABSSSI) and osteomyelitis within infectious ...
Alastair Gray +10 more
doaj +2 more sources
Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection. [PDF]
Antimicrobial Agents and Chemotherapy, 2019 Mark H. Wilcox, Xiaoju Lv
exaly +2 more sources
Antibiotics, 2022 The antibiotic dalbavancin is approved for intravenous treatment of adults with acute bacterial skin and skin structure infections. This study aimed to observe the use, effectiveness, and safety of dalbavancin in clinical practice in Germany.
Frank Hanses +4 more
doaj +1 more source
Journal of Infection and Public Health, 2023 Background: The treatment of acute bacterial skin and skin structure infections (ABSSSI) usually involves intravenous (i.v.) antibiotics requiring hospitalisation and increasing hospital costs.
Christoph T. Baltin +10 more
doaj +1 more source